Scientist / Sr Scientist, Metabolic Disease

Sigilon Therapeutics is a multidisciplinary biotechnology company which specializes in creating immune privileged products to address unmet clinical needs. Our mission at Sigilon Therapeutics is to create immune-protected, engineered human cells that restore normal physiology in a wide range of diseases without generating fibrosis or immune rejection, liberating patients from challenges associated with serious chronic diseases. We are based in Kendall Square in Cambridge, MA, and funded by Flagship Pioneering. Please send your application via email to

Sigilon Therapeutics is searching for an energized and highly motivated Scientist to be part of a team focused on developing a novel therapeutic product for metabolic diseases utilizing Sigilon’s Afibromer™ technology combined with synthetic biology technology. The candidate should have experience with molecular biology, cell biology, protein chemistry, and in vivo pharmacology.